Key result
Minicrush links to comparable TLF versus TAP but ~86% lower stent thrombosis.
Why the study?
Limited contemporary data exist comparing alternative upfront 2-stent approaches, particularly Minicrush versus TAP stenting, in complex coronary bifurcation lesions.
Does the Minicrush stenting technique reduce target lesion failure compared to T-stenting and minimal protrusion (TAP) in patients undergoing percutaneous coronary intervention for complex coronary bifurcation lesions?
Cohort (n=469)
Yes
Does the Minicrush stenting technique reduce target lesion failure compared to T-stenting and minimal protrusion (TAP) in patients undergoing percutaneous coronary intervention for complex coronary bifurcation lesions?
Minicrush and TAP stenting techniques offer comparable long-term efficacy for complex coronary bifurcation lesions, but Minicrush is associated with a significantly lower risk of stent thrombosis.
Answers are grounded in this paper and cite their sources.
Minicrush was associated with lower stent thrombosis than TAP without differing target lesion failure; leaves open need for randomized confirmation in bifurcation PCI.
BACKGROUND: Percutaneous coronary intervention of complex coronary bifurcation lesions frequently requires an upfront 2-stent strategy. Although the double kissing crush technique has been extensively studied, limited contemporary data are available comparing alternative 2-stent approaches, particularly Minicrush and T-stenting and minimal protrusion (TAP), in complex bifurcation anatomy. This study aimed to compare procedural characteristics and long-term clinical outcomes of Minicrush versus TAP stenting techniques in patients undergoing percutaneous coronary intervention for complex coronary bifurcation lesions. METHODS: The TREX registry is a multicenter, retrospective cohort study including consecutive patients treated with an upfront 2-stent strategy using Minicrush or TAP between November 2015 and April 2025. The primary end point was target lesion failure. Secondary end points included major adverse cardiac events and definite or probable stent thrombosis. Clinical outcomes were assessed for up to 10 years. RESULTS: Among 601 screened patients, 469 (78%) underwent an upfront 2-stent strategy (Minicrush: n=257; TAP: n=212). TLF occurred in 10.4% of patients, with no significant differences between groups at 1, 5, or 10 years. Major cardiovascular event rates were also comparable across all time points. In multivariable analyses, distal left main involvement and severe coronary calcification were the strongest predictors of TLF, whereas reduced left ventricular ejection fraction was the main predictor of major cardiovascular events. Definite or probable stent thrombosis occurred more frequently with TAP than with Minicrush (5.7% versus 0.8%; P <0.01). CONCLUSIONS: Minicrush and TAP provide comparable long-term efficacy in complex coronary bifurcation percutaneous coronary intervention; however, Minicrush is associated with a lower risk of stent thrombosis, suggesting a more favorable safety profile. REGISTRATION: URL: https://clinicaltrials.gov/ ; Unique Identifier: NCT06484647.
No takes yet. Share an insight, caveat, or question.
Piedimonte et al. (2026) conducted a cohort in Complex coronary bifurcation lesions (n=469). Minicrush vs. T-stenting and minimal protrusion (TAP) was evaluated on Target lesion failure. In patients with complex coronary bifurcation lesions, Minicrush and TAP had comparable target lesion failure rates, but Minicrush had lower stent thrombosis.
Synapse has enriched 10 related papers. Consider them for comparative context: